Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Adherence of PCSK9 Targeted Therapy: A Retrospective Analysis of Japan Databases

NCT07468500 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT07468500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07468500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Adherence of PCSK9 Targeted Therapy: A Retrospective Analysis of Japan Databases
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Not yet recruiting
Start date
March 30, 2026
Completion date
July 30, 2026
Enrollment
3,600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, hypercholesterolemia